EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Protective mechanisms against Alzheimer's disease in APOE3‐Christchurch homozygous astrocytes

Xinran Tian, Erica Keane Rivera, Inyoung Hwang, Arina A Nikitina, Jennifer A Smith, Youngsuh J Cho, Julia Sala-Jarque, Austin DuBose, Clare Andriola, Toby Gollan-Myers, Kenneth S Kosik

Alzheimer's & Dementia · 2025-09 · 21 (9)

DOI: 10.1002/alz.70589 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 18.09.2025. Verfasst von Xinran Tian und 10 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Research Institute, Department of Molecular, Cellular, and Developmental Biology, University of California Santa Barbara, Santa Barbara,…. Hauptthemen laut MEDLINE: Astrocytes, Alzheimer Disease, Apolipoprotein E3, tau Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Alzheimer's disease (AD) is characterized by tau pathology, leading to neurodegeneration. Astrocytes regulate central nervous system homeostasis and influence AD progression. The APOE3‐Christchurch (APOE3‐Ch) variant is linked to AD resilience, but its protective mechanisms remain unclear. METHODS Human induced pluripotent stem cell–derived astrocytes (APOE3‐Ch and wild type) were used to assess tau uptake, clearance, lipid metabolism, and transcriptomic adaptations. Fluorescently labeled 2N4R‐P301L tau oligomers were tracked, and pathway‐specific inhibitors dissected tau clearance mechanisms. Lipidomic and transcriptomic analyses were performed to identify genotype‐specific adaptations. RESULTS APOE3‐Ch astrocytes exhibited enhanced tau uptake via heparan sulfate proteoglycan‐ and lipoprotein receptor‐related protein 1‐mediated pathways and superior clearance through lysosomal and proteasomal degradation. They exported less tau, limiting propagation. Transcriptomic analyses revealed upregulation of genes involved in cell projection assembly and endocytosis. Lipidomic profiling showed reduced ceramides and gamma‐linolenic acid, linked to decreased neuroinflammation and ferroptosis. DISCUSSION APOE3‐Ch astrocytes promote tau clearance and metabolic adaptations, providing insights into genetic resilience in AD and potential therapeutic targets. Highlights APOE3‐Christchurch (APOE3‐Ch) astrocytes exhibit significantly increased tau internalization compared to wild‐type astrocytes, facilitated by upregulated heparan sulfate proteoglycan and low‐density lipoprotein receptor‐related protein 1 pathways. APOE3‐Ch astrocytes demonstrate more efficient tau degradation via both lysosomal and proteasomal pathways, while exporting significantly less tau, potentially reducing tau propagation in the central nervous system. APOE3‐Ch astrocytes show upregulation of genes involved in cell projection assembly and endocytosis, suggesting structural and functional modifications that enhance tau processing. Lipidomic profiling reveals reduced ceramide levels and gamma‐linolenic acid downregulation in APOE3‐Ch astrocytes, alterations linked to reduced neuroinflammatory and ferroptotic activity, contributing to the protective phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AstrocytesAlzheimer DiseaseApolipoprotein E3tau ProteinsHumansHomozygoteInduced Pluripotent Stem CellsLipid Metabolism

Stichwörter der Autor:innen

APOE3‐ChristchurchAlzheimer's diseaseendolysosomal traffickingheparan sulfate proteoglycansinduced pluripotent stem cell–derived astrocyteslipid metabolismlipoprotein receptor‐related protein 1lysosomal degradationproteasomal degradationtau oligomerstau pathology

Substanzen

Apolipoprotein E3tau Proteins

Autor:innen und Institutionen

  • Neuroscience Research Institute, Department of Molecular, Cellular, and Developmental Biology, University of California Santa Barbara, Santa Barbara, California, USA.
  • Department of Chemistry and Biochemistry, University of California Santa Barbara, Santa Barbara, California, USA.
  • Biological Nanostructures Laboratory, University of California Santa Barbara, Santa Barbara, California, USA.

Förderung

  • NIA NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Tian, X., Rivera, E. K., Hwang, I., Nikitina, A. A., Smith, J. A., Cho, Y. J., Sala-Jarque, J., DuBose, A., Andriola, C., Gollan-Myers, T., & Kosik, K. S. (2025). Protective mechanisms against Alzheimer's disease in APOE3‐Christchurch homozygous astrocytes. Alzheimer's & Dementia, 21(9). https://doi.org/10.1002/alz.70589

Vancouver

Tian X, Rivera EK, Hwang I, Nikitina AA, Smith JA, Cho YJ, et al. Protective mechanisms against Alzheimer's disease in APOE3‐Christchurch homozygous astrocytes. Alzheimer's & Dementia. 2025;21(9). doi:10.1002/alz.70589

BibTeX
@article{Tian2025,
  author = {Tian, Xinran and Rivera, Erica Keane and Hwang, Inyoung and Nikitina, Arina A and Smith, Jennifer A and Cho, Youngsuh J and Sala-Jarque, Julia and DuBose, Austin and Andriola, Clare and Gollan-Myers, Toby and Kosik, Kenneth S},
  title = {Protective mechanisms against Alzheimer's disease in APOE3‐Christchurch homozygous astrocytes},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {9},
  doi = {10.1002/alz.70589}
}
Kostenlos starten →